Scientists said Keven's finding was very important, especially because two-thirds of colon cancer patients are elderly, and previous drug research has mostly only separated children from adults but not young adults versus elderly. Keven already won awards from science fairs, including the prestigious Intel International Science and Engineering Fair last year. He is currently a biomedical engineering sophomore at the University of Wisconsin - Madison (he won six scholarships to attend college there). He did an internship at the University of Chicago Comprehensive Cancer Center this summer.
Read more about his inspiring story and research here: